York, in the matter of Exactech, Inc

Link copied
Case Copied 22 min read

FEDERAL COURT OF AUSTRALIA

York, in the matter of Exactech, Inc [2024] FCA 1522

File number(s): NSD 1842 of 2024
Judgment of: HALLEY J
Date of judgment: 23 December 2024
Catchwords:

BANKRUPTCY AND INSOLVENCY – application for stay pending recognition of foreign proceeding as a foreign main proceeding pursuant to the Cross-Border Insolvency Act 2008 (Cth) and the Model Law on Cross-Border Insolvency of the United Nations Commission on International Trade Law – whether proceeding likely to be recognised as a foreign main proceeding – whether interim relief urgently needed to protect the assets of the debtor or the interests of the creditors – orders made

PRACTICE AND PROCEDURE – application to dispense with r 15A.6 and r 15A.7 of the Federal Court (Corporations) Rules 2000 (Cth) – where plaintiff sought customised notification regime – orders made

Legislation:

Cross-Border Insolvency Act 2008 (Cth) ss 10 and 13

Cross-Border Insolvency Act 2008 (Cth) Sch 1, Model Law on Cross-Border Insolvency of the United Nations Commission on International Trade Law (UNCITRAL), arts 2, 15, 16, 17, 19

Federal Court (Corporations) Rules 2000 (Cth) rr 1.8, 15A.6 and 15A.7

Cases cited:

Asafuji (in his capacity as the Foreign Representative of the Sanko Steamship Co., Ltd) v The Sanko Steamship Co., Ltd [2012] FCA 1154

Bradley, Astora Women's Health, LLC v Astora Women's Health, LLC (No 2) [2022] FCA 1268

Bradley, Astora Women's Health, LLC v Astora Women's Health, LLC [2022] FCA 1195

Hur v Samsun Logix Corporation [2009] FCA 372

Kapila, in the matter of Edelsten (2014) 320 ALR 506; [2014] FCA 1112

Moore as Debtor-in-Possession of Australian Equity Investors v Australian Equity Investors [2012] FCA 1002

Tucker, in the matter of Aero Inventory (UK) Limited v Aero Inventory (UK) Limited (2009) 76 ACSR 19; [2009] FCA 1354

Young, Jr, in the matter of Buccaneer Energy Limited v Buccaneer Energy Limited [2014] FCA 711

Division: General Division
Registry: New South Wales
National Practice Area: Commercial and Corporations
Sub-area: Corporations and Corporate Insolvency
Number of paragraphs: 58
Date of hearing: 23 December 2024
Counsel for the Plaintiff: Ms E L Beechey
Solicitor for the Plaintiff: Clayton Utz
Counsel for the Defendant: The Defendant did not appear

ORDERS

NSD 1842 of 2024

IN THE MATTER OF EXACTECH, INC

BETWEEN:

JESSE YORK IN HIS CAPACITY AS FOREIGN REPRESENTATIVE OF EXACTECH, INC

Plaintiff

AND:

EXACTECH, INC

Defendant

ORDER MADE BY:

HALLEY J

DATE OF ORDER:

23 DECEMBER 2024

THE COURT ORDERS THAT:

1.Pursuant to Art 19(1)(a) of the Model Law on Cross-Border Insolvency of the United Nations Commission on International Trade Law (Model Law), that until the application for relief under Art 17 of the Model Law made in the Originating Process in this proceeding is decided, or until further order of the Court:

(a)any and all execution against the assets of the Defendant, Exactech, Inc. (Exactech) be stayed;

(b)no person within the jurisdiction of the Court other than Exactech may transfer, encumber or otherwise dispose of, or take possession of…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read York, in the matter of Exactech, Inc and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2024] FCA 1522
Decision Date

CaseChat Overview and Summary

The matter before the Court was an application by Mr York, as the Chief Restructuring Officer of Exactech, Inc., to obtain an interim stay of proceedings against Exactech, pending the determination of an application for recognition of a foreign main proceeding. The case involved the potential recognition of a Chapter 11 bankruptcy proceeding in the United States as a foreign main proceeding under the Cross-Border Insolvency Act 2008 (Cth) and the Model Law on Cross-Border Insolvency of the United Nations Commission on International Trade Law. The primary legal issues were whether the Chapter 11 proceeding was likely to be recognised as a foreign main proceeding and whether interim relief was urgently needed to protect the assets of the debtor or the interests of the creditors.

The Court found that there was a reasonable prospect that the Chapter 11 proceeding would be recognised as a foreign main proceeding, given the significant litigation and financial challenges faced by Exactech and its group companies. The Court also determined that interim relief was urgently needed to protect the assets of Exactech and the interests of its creditors, particularly in light of the extensive litigation and the potential for asset dissipation. Consequently, the Court granted an interim stay pursuant to art 19 of the Model Law, pending the final determination of the Model Law application.

Additionally, the Court made orders dispensing with certain notification requirements under the Federal Court (Corporations) Rules 2000 (Cth) and directing a customised notification regime for potential creditors and other interested parties. These orders were designed to ensure that the interim stay was effective and that relevant parties were appropriately informed of the proceedings.

The final orders included an interim stay of any execution against Exactech's assets, prohibitions on the transfer or encumbrance of Exactech's assets, and restrictions on initiating or proceeding with any proceedings against Exactech or its property. The orders also specified a customised notification regime for the Class Action applicants and other identified parties, and listed the originating process for hearing on 6 February 2025.

Orders

Orders of the court

1. Pursuant to Art 19(1)(a) of the Model Law on Cross-Border Insolvency of the United Nations Commission on International Trade Law (Model Law), that until the application for relief under Art 17 of the Model Law made in the Originating Process in this proceeding is decided, or until further order of the Court:

(a) any and all execution against the assets of the Defendant, Exactech, Inc. (Exactech) be stayed;

(b) no person within the jurisdiction of the Court other than Exactech may transfer, encumber or otherwise dispose of, or take possession of or otherwise recover, any assets of Exactech;

(c) no proceeding against Exactech, or in relation to any of its property, may be begun or proceeded with, save that for the avoidance of any doubt the stay does not prevent the following steps occurring in Federal Court of Australia Proceeding NSD 1224 of 2024 (Class Action):

(i) the issue of any notice(s) to group members (notices) regarding group member opt out, registration of group member interest, mediation and any settlement approval that may ultimately be sought;

(ii) applying for leave to issue, and issuing subpoenas for production for the purpose of identifying group members, and /or obtaining their contact details for the distribution of notices; and

(iii) preparation for and participation in any mediation and/or settlement discussions in which Exactech agrees to participate and the seeking of court approval for any settlement that may ultimately be agreed;

(d) no receiver may be appointed to any of the assets of Exactech, nor may any step be taken to enforce any security over any of the assets of Exactech in Australia.

2. The requirements of 15A.3(4)(a) and 15A.6(1) of the Federal Court (Corporations) Rules 2000 (Cth) be dispensed with and in lieu thereof the Plaintiff distribute the form appearing in the Schedule to these Orders (Notice) as follows:

(a) within 15 business days of the making of these orders, the Plaintiff give the Notice to the applicant in the Class Action by sending a copy of the Notice to the applicants' solicitors, Gerard Malouf & Partners, once by way of email to david@gmp.net.au and once by ordinary post;

(b) within 15 business days of the making of these orders, the Plaintiff to give the Notice to the persons identified in paragraphs 30 and 42 of the affidavit affirmed by Jesse York in this proceeding on 19 December 2024 by sending the Notice to the postal address and last known email address (where known) of each of the persons, or to their solicitors where legally represented once by way of email and once by ordinary post.

3. Any party affected by these orders is at liberty to apply upon five business days' notice.

4. The originating process filed 19 December 2024 be listed for hearing at 10.15 am on Thursday, 6 February 2025.

Schedule

[The order entered is available on the Commonwealth Courts Portal, which attaches the Schedule]

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

These are my reasons for making those orders.B. BACKGROUND Mr York is the Chief Restructuring Officer of Exactech. Exactech is a US company incorporated and headquartered in Florida. It is relevantly a manufacturer and developer of orthopaedic implant devices. Its products relevantly include hip implants, knee implants, and shoulder implants. Exactech distributes its products to markets throughout the United States, Europe, South America, Asia, and Australia. Exactech is part of the Exactech Group, the ultimate parent company of which is Osteon Holdings, Inc (Osteon). Exactech is the main operating company for the Exactech Group’s United States’ operations. Since 2021, various Exactech Group companies have faced significant litigation stemming from certain product recalls. In particular, Exactech, in coordination with the United States Food and Drug Administration, voluntarily recalled certain knee, hip and shoulder components which had been distributed in non-conforming packaging. More than 2,585 patients have filed lawsuits in multiple Federal, State, and non-United States courts alleging damages relating primarily to the non-conforming packaging and resulting recalls. Separately, Exactech has been defending “qui tam claims”, being claims brought by individuals on behalf of a State or the Federal government of the United States. These claims were originally filed in 2018 in the Northern District of Alabama, which, together with a separate investigation initiated in 2023, involve allegations that Exactech’s sale of certain knee devices violated the False Claims Act and similar State statutes. As of 29 October 2024, Exactech had approximately $606 million in total assets and approximately $485 million in total liabilities, not including any liabilities that Exactech may have as a result of the pending litigation or other potential litigation. In Australia, Exactech’s products are distributed by Exactech Australia Pty Ltd (Exactech Australia). Exactech Australia is an indirect subsidiary of Exactech. Exactech Australia is not in any form of external administration. In the period between 21 August 2021 and 7 March 2024, Exactech Australia, in consultation with the Australian Therapeutic Goods Administration, recalled knee, hip and shoulder components manufactured by Exactech and packaged in non-conforming packaging that Exactech Australia had distributed in Australia. A class action was commenced against Exactech Australia and Exactech in this Court in September 2024, being proceeding NSD 1224 of 2024 (Class Action). On 29 October 2024, Exactech, Osteon and three other companies in the Exactech Group each filed voluntary petitions in the US Bankruptcy Court to commence bankruptcy proceedings under Chapter 11 of Title 11 of the United States Bankruptcy Code. The US Bankruptcy Court subsequently ordered that the five Chapter 11 proceedings be consolidated for administrative purposes under Case No. 24-12441.C. INTERIM STAYC.1. Overview Whether the interim relief sought by Mr York should be granted turned on first, the strength of Mr York’s case for recognition of the Chapter 11 Proceeding as a foreign main proceeding and the relief likely to be granted at the hearing, and second, whether the interim relief was urgently needed to protect the assets of the debtor or the interests of the creditors.C.2. Relevant Principles

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established

On 23 December 2024, I made an order granting an interim stay pursuant to art 19 of the Model Law, pending final determination of the Model Law application on 6 February 2025. I also made orders providing for directions for notifying potential creditors and other persons who may have an interest in the Model Law application, in place of the requirements for notification set out in r 15A.6 and r 15A.7 of the Federal Court (Corporations) Rules 2000 (Cth) (Corporations Rules). Mr York relied on his affidavit that he affirmed on 18 December 2024 (in Connecticut, United States)/19 December 2024 (in Sydney, Australia), together with Exhibit JY-1 to that affidavit. These are my reasons for making those orders.B. BACKGROUND Mr York is the Chief Restructuring Officer of Exactech. Exactech is a US company incorporated and headquartered in Florida. It is relevantly a manufacturer and developer of orthopaedic implant devices. Its products relevantly include hip implants, knee implants, and shoulder implants. Exactech distributes its products to markets throughout the United States, Europe, South America, Asia, and Australia. Exactech is part of the Exactech Group, the ultimate parent company of which is Osteon Holdings, Inc (Osteon). Exactech is the main operating company for the Exactech Group’s United States’ operations. Since 2021, various Exactech Group companies have faced significant litigation stemming from certain product recalls. In particular, Exactech, in coordination with the United States Food and Drug Administration, voluntarily recalled certain knee, hip and shoulder components which had been distributed in non-conforming packaging. More than 2,585 patients have filed lawsuits in multiple Federal, State, and non-United States courts alleging damages relating primarily to the non-conforming packaging and resulting recalls. Separately, Exactech has been defending “qui tam claims”, being claims brought by individuals on behalf of a State or the Federal government of the United States. These claims were originally filed in 2018 in the Northern District of Alabama, which, together with a separate investigation initiated in 2023, involve allegations that Exactech’s sale of certain knee devices violated the False Claims Act and similar State statutes. As of 29 October 2024, Exactech had approximately $606 million in total assets and approximately $485 million in total liabilities, not including any liabilities that Exactech may have as a result of the pending litigation or other potential litigation. In Australia, Exactech’s products are distributed by Exactech Australia Pty Ltd (Exactech Australia). Exactech Australia is an indirect subsidiary of Exactech. Exactech Australia is not in any form of external administration. In the period between 21 August 2021 and 7 March 2024, Exactech Australia, in consultation with the Australian Therapeutic Goods Administration, recalled knee, hip and shoulder components manufactured by Exactech and packaged in non-conforming packaging that Exactech Australia had distributed in Australia.